Fondren Management LP lowered its stake in shares of Alphatec Holdings Inc (NASDAQ:ATEC) by 34.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 250,301 shares of the medical technology company’s stock after selling 129,699 shares during the quarter. Fondren Management LP’s holdings in Alphatec were worth $666,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the business. Renaissance Technologies LLC boosted its position in Alphatec by 10.2% during the fourth quarter. Renaissance Technologies LLC now owns 359,087 shares of the medical technology company’s stock worth $955,000 after purchasing an additional 33,300 shares during the period. Armistice Capital LLC boosted its position in Alphatec by 18.2% during the fourth quarter. Armistice Capital LLC now owns 778,414 shares of the medical technology company’s stock worth $2,071,000 after purchasing an additional 120,000 shares during the period. Broadfin Capital LLC bought a new stake in Alphatec during the fourth quarter worth approximately $387,000. Finally, HPM Partners LLC bought a new stake in Alphatec during the fourth quarter worth approximately $515,000. 18.25% of the stock is owned by hedge funds and other institutional investors.
Shares of Alphatec Holdings Inc (NASDAQ ATEC) opened at $3.14 on Wednesday. Alphatec Holdings Inc has a 12-month low of $1.58 and a 12-month high of $4.27. The company has a debt-to-equity ratio of -1.11, a quick ratio of 1.08 and a current ratio of 2.11.
A number of brokerages have issued reports on ATEC. HC Wainwright set a $4.00 target price on Alphatec and gave the stock a “buy” rating in a research report on Tuesday. Zacks Investment Research raised Alphatec from a “sell” rating to a “hold” rating in a research report on Tuesday, January 23rd. Finally, ValuEngine cut Alphatec from a “sell” rating to a “strong sell” rating in a research report on Friday, December 1st.
Alphatec Company Profile
Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.
Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings Inc (NASDAQ:ATEC).
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.